Biotech Shares Up Sharply Following Quarterly Results

Biotech Shares Up Sharply Following Quarterly Results

By: Tomas Ronolski - News

Wednesday, November 15, 2023

A California-based biotech company is stealing the show so far during Wednesday’s session following yesterday’s earnings beat. According to some analysts, the company beat EPS by $0.14.

Shares of  Heron Therapeutics Inc. (Nasdaq:HRTX) rallied strongly up to $0.895/share (+65.74%) at the early session high after traders were able to digest the financial information. This move goes hand in hand with the massive uplift the biotech sector has gotten over the last few months.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Copyright © 2023 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Sugar Demand Helps This Firm Report Solid Q4 Results
Fed’s Preferred Inflation Measure Shows Cooling
Dual-Listed Junior Miner Announces Progress in Uranium Quest
Most Popular
FREE Newsletter

Back to Top